Abstract:Background/aim: Radiation therapy is pivotal in cancer treatment; however, its efficacy is limited by challenges such as tumor recurrence. This study delves into the role of exosomes, which are molecular cargo-bearing vesicles, in influencing cell proliferation, radioresistance, and consequent post-irradiation tumor recurrence. Given the significance of exosomes from irradiated malignancies in diagnostics and therapy, it is vital to delineate their functional dynamics, especially in breast and cervical cancer cell lines, where the impact of irradiation on exosome behavior remains enigmatic. Materials and methods: Using MDA-MB-231 and HeLa cell lines, exosomes were isolated from the culture supernatant via ultracentrifugation. The bicinchoninic acid assay was used to measure exosome quantities in irradiated and non-irradiated cells. Radiosensitivity was assessed using colony formation assays, while the role of the MAPK/Erk signaling pathway in recipient cell proliferation and radioresistance was probed using western blotting. Results: Irradiated cells, in both MDA-MB-231 and HeLa lines, produced significantly more exosomes than their non-irradiated counterparts. Co-culturing irradiated cells with exosomes led to increased cell survival post-irradiation and enhanced cell proliferation in both cell lines. Western blotting indicated elevated p-Erk expression in such cells, underscoring the influence of the MAPK/Erk pathway in radioresistance and proliferation. Conclusion: The study establishes a potential nexus between exosome secretion and tumor resurgence following radiotherapy. The spotlight falls on the MAPK/ERK signaling conduit as a key influencer. This new knowledge provides an innovative strategy for counteracting cancer recurrence after radiotherapy, emphasizing the importance of understanding the multifaceted roles of exosomes in this context.

The emerging role of exosomes in radiotherapy

Exosomes Participate in the Radiotherapy Resistance of Cancers

Exosome: Emerging Biomarker in Breast Cancer

Exosomes Reveal the Dual Nature of Radiotherapy in Tumor Immunology

Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity

Research Progress on Exosomes in Radiotherapy for Malignant Tumors

Mediation of radiation-induced bystander effect and epigenetic modification: The role of exosomes in cancer radioresistance

Exosome-mediated cellular crosstalk within the tumor microenvironment upon irradiation

Biological Effects of Radiation-Induced Exosomes

Advances of exosome research in cancer radiotherapy and chemotherapy

Radiation-Induced Bystander Effect can be Transmitted Through Exosomes Using miRNAs as Effector Molecules

Exosomes and exosomal microRNA in non-targeted radiation bystander and abscopal effects in the central nervous system

The Footprint of Exosomes in the Radiation-Induced Bystander Effects

Irradiated Cell-derived Exosomes Enhance Cell Proliferation and Radioresistance via the MAPK/Erk Pathway

The Role of Radiation-Induced Exosomes in Tumor Invasion and Metastasis

Emerging role of mesenchymal stem cell-derived exosome microRNA in radiation injury

Tissue-specific and exosomal miRNAs in lung cancer radiotherapy: from regulatory mechanisms to clinical implications

Exosomes: the Role in Tumor Tolerance and the Potential Strategy for Tumor Therapy

The Role of Exosomes and Their Applications in Cancer

The Role and Clinical Applications of Exosomes in Cancer Drug Resistance

Exosome: a novel mediator in drug resistance of cancer cells.